Sarepta Therapeutics (SRPT) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for Sarepta Therapeutics (SRPT) over the last 15 years, with Q3 2025 value amounting to -$158.0 million.
- Sarepta Therapeutics' Other Gross PP&E Adjustments fell 1213.15% to -$158.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$158.0 million, marking a year-over-year decrease of 1213.15%. This contributed to the annual value of $408.5 million for FY2024, which is 5073.9% up from last year.
- Sarepta Therapeutics' Other Gross PP&E Adjustments amounted to -$158.0 million in Q3 2025, which was down 1213.15% from -$169.7 million recorded in Q2 2025.
- In the past 5 years, Sarepta Therapeutics' Other Gross PP&E Adjustments registered a high of $408.5 million during Q4 2024, and its lowest value of -$170.6 million during Q1 2025.
- For the 5-year period, Sarepta Therapeutics' Other Gross PP&E Adjustments averaged around -$28.2 million, with its median value being -$81.5 million (2021).
- As far as peak fluctuations go, Sarepta Therapeutics' Other Gross PP&E Adjustments surged by 5131.54% in 2021, and later plummeted by 17670.15% in 2023.
- Over the past 5 years, Sarepta Therapeutics' Other Gross PP&E Adjustments (Quarter) stood at $248.9 million in 2021, then rose by 1.21% to $251.9 million in 2022, then rose by 7.58% to $271.0 million in 2023, then skyrocketed by 50.74% to $408.5 million in 2024, then tumbled by 138.68% to -$158.0 million in 2025.
- Its last three reported values are -$158.0 million in Q3 2025, -$169.7 million for Q2 2025, and -$170.6 million during Q1 2025.